342 related articles for article (PubMed ID: 3813593)
1. Mast cell numbers in diffuse scleroderma.
Nishioka K; Kobayashi Y; Katayama I; Takijiri C
Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
[TBL] [Abstract][Full Text] [Related]
2. [Type I and II collagens and mast cells expression in the skin lesions from the patients with localized scleroderma].
Wielowieyska-Szybińska D; Wojas-Pelc A; Dyduch G; Zawisz A
Przegl Lek; 2008; 65(4):161-5. PubMed ID: 18724540
[TBL] [Abstract][Full Text] [Related]
3. [Distribution of fibronectin in the skin of patients with scleroderma].
Birembaut P; Cahuzac P; Delhomme H; Caron Y; Labat-Robert J; Robert L; Kalis B
Ann Dermatol Venereol; 1982; 109(11):933-7. PubMed ID: 6762839
[TBL] [Abstract][Full Text] [Related]
4. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
Ozbilgin MK; Inan S
Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
[TBL] [Abstract][Full Text] [Related]
5. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.
Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y
Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789
[TBL] [Abstract][Full Text] [Related]
6. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?
Hawkins RA; Claman HN; Clark RA; Steigerwald JC
Ann Intern Med; 1985 Feb; 102(2):182-6. PubMed ID: 3966756
[TBL] [Abstract][Full Text] [Related]
7. Extracellular microfibrils are increased in localized and systemic scleroderma skin.
Fleischmajer R; Jacobs L; Schwartz E; Sakai LY
Lab Invest; 1991 Jun; 64(6):791-8. PubMed ID: 2046331
[TBL] [Abstract][Full Text] [Related]
8. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
9. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
10. Photofibrosis: a further histopathological change induced by PUVA therapy via the mast cell in guttate psoriasis. Preliminary report.
Borroni G; Vignati G; Zaccone C; Gorani A; Brazzelli V; Rabbiosi G
Acta Derm Venereol Suppl (Stockh); 1994; 186():159-61. PubMed ID: 8073822
[TBL] [Abstract][Full Text] [Related]
11. Quantification of mast cells and blood vessels in the skin of patients with cutaneous mucinosis.
Martins C; Nascimento AP; Monte-Alto-Costa A; Alves Mde F; Carneiro SC; Porto LC
Am J Dermatopathol; 2010 Jul; 32(5):453-8. PubMed ID: 20442641
[TBL] [Abstract][Full Text] [Related]
12. Mast cells and fibrosis. The relevance to scleroderma.
Claman HN
Rheum Dis Clin North Am; 1990 Feb; 16(1):141-51. PubMed ID: 2406804
[TBL] [Abstract][Full Text] [Related]
13. [Increased retraction of collagen lattices by fibroblasts from patients with scleroderma].
Gillery P; Maquart FX; Kalis B; Borel JP
C R Acad Sci III; 1986; 303(3):59-64. PubMed ID: 3093006
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD1a and CD86 on scleroderma Langerhans cells.
Xie Y; Zhang X; Inoue Y; Wakasugi S; Makino T; Ihn H
Eur J Dermatol; 2008; 18(1):50-4. PubMed ID: 18086589
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema.
Järvikallio A; Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
17. Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.
Irani AM; Gruber BL; Kaufman LD; Kahaleh MB; Schwartz LB
Arthritis Rheum; 1992 Aug; 35(8):933-9. PubMed ID: 1642658
[TBL] [Abstract][Full Text] [Related]
18. Sequential dermal microvascular and perivascular changes in the development of scleroderma.
Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P
J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881
[TBL] [Abstract][Full Text] [Related]
19. Study of mast cells in non-neoplastic skin lesions.
Naik R; Pai MR; Bantwal PB; Shankarnarayana ; Nayak KS; Gandhi A
Indian J Pathol Microbiol; 2003 Apr; 46(2):173-5. PubMed ID: 15022902
[TBL] [Abstract][Full Text] [Related]
20. Morphologic and histochemical changes in the skin of patients with scleroderma.
Ieremia G; Raica M; Cîmpean AM; Bocan V
Rom J Morphol Embryol; 2007; 48(4):361-7. PubMed ID: 18060186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
